, Guide e-learning rapport complet : Guide de conception de formation ouverte et à distance (FOAD) dans le monde de la santé, HAS, 2015.

J. Wirt, W. J. Choy, S. Rooney, P. Provasnik, S. Sen et al., The Condition of Education, 2004.

. Ministère-de-l'emploi, CIRCULAIRE DGEFP n°2001/22 du 20 juillet 2001 relative aux formations ouvertes et/ou à distance « FOAD

, Développement professionnel continu fiche méthode : e-learning, HAS, 2014.

A. M. Leaving, A. , and S. Alexandria, , 2012.

V. Caraguel, Appropriation des technologies et apprentissage dans un environnement en e-learning : le rôle du tutorat en ligne, 2013.

, Code De La Propriété Intellectuelle. Article L-111-1 à L112-4

, Code de la Santé Publique Article L110-4

O. B. Christensen, M. Hindsén, and Å. Svensson, Natural history of dermatitis herpetiformis in southern Sweden, Dermatologica, vol.173, issue.6, p.271, 1986.

T. T. Salmi, K. Hervonen, H. Kautiainen, P. Collin, and T. Reunala, Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland, Br J Dermatol, vol.165, issue.2, pp.354-363, 2011.

D. B. Buckley, J. English, W. Molloy, C. T. Doyle, and M. J. Whelton, Dermatitis herpetiformis: a review of 119 cases, Clin Exp Dermatol, vol.8, issue.5, pp.477-87, 1983.

D. Bolotin and V. Petronic-rosic, Dermatitis herpetiformis: Part II. Diagnosis, management, and prognosis, Journal of the American Academy of Dermatology, vol.64, issue.6, pp.1027-1060, 2011.

J. Alonso-llamazares, L. E. Gibson, and R. S. Rogers, Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience, International Journal of Dermatology, vol.46, issue.9, pp.910-919, 2007.

K. Nakajima, Recent Advances in Dermatitis Herpetiformis, Clin Dev Immunol, p.914162, 2012.

P. E. Mccleskey, Q. L. Erickson, K. M. David-bajar, and D. M. Elston, Palmar petechiae in dermatitis herpetiformis: a case report and clinical review, Cutis, vol.70, issue.4, pp.217-240, 2002.

L. Fry, J. N. Leonard, F. Swain, W. F. Tucker, G. Haffenden et al., Long-term follow-up of dermatitis herpetiformis with and without diettary gluten withdrawal, Br J Dermatol, vol.107, issue.6, pp.631-671, 1982.

D. N. Silvers, E. A. Juhlin, P. H. Berczeller, and J. Mcsorley, Treatment of dermatitis herpetiformis with colchicine, Arch Dermatol, vol.116, issue.12, pp.1373-84, 1980.

A. Zemtsov and K. H. Neldner, Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate, Dapsone J Am Acad Dermatol, vol.28, issue.3, pp.505-511, 1993.

.. Pnds, , 2016.

S. Ingen-housz-oro,

, Ann Dermatol Venereol, vol.138, issue.3, pp.214-234, 2011.

M. K. Kuechle, E. Stegemeir, B. Maynard, L. E. Gibson, K. M. Leiferman et al., Drug induced linear IgA bullous dermatosis : report of six cases and review of the literature, J Am Acad Dermatol, vol.30, issue.2, pp.187-92, 1994.

S. Ingen-housz-oro, L. Valeyrie-allanore, and J. Chanal, Linear immunoglobulin A disease and vancomycin : letter in reply, Br J Dermatol, vol.171, issue.6, pp.1602-1604, 2014.

J. M. Acostamadiedo, C. Perniciaro, and R. S. Rogers, Phenytoïne induced linear IgA bullous disease, J Am Acad Dermatol, vol.38, issue.2, pp.352-358, 1998.

M. B. Bouldin, H. E. Clowers-webb, and J. L. Davis, Naproxen-associated linear IgA bullous dermatosis : case report and review, Mayo Clin Proc, vol.75, issue.9, pp.967-70, 2000.

I. S. Friedman, D. Rudikoff, R. G. Phelps, and A. N. Sapadin, Captopril triggered linear IgA bullous dermatosis, Int J Dermatol, vol.37, issue.8, pp.608-620, 1998.

J. Gottlieb, S. Ingen-housz-oro, and A. M. , Idiopathic linear IgA bullous dermatosis : prognostic factors based on a case-series of 72 adults, Br J Dermatol, vol.177, issue.1, pp.212-222, 2017.

G. Fortuna and M. P. Marinkovich, Linear immunoglobulin A bullous dermatosis, Clin Dermatol, vol.30, issue.1, pp.38-50, 2012.

F. Wojnarowska, R. A. Marsden, B. Bhogal, and M. M. Black, Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap, J Am Acad Dermatol, vol.19, issue.5, pp.792-805, 1988.

J. Yamagami, Y. Nakamura, and K. Nagao, Vancomycin Mediates IgA Autoreactivity in Drug-Induced Linear IgA Bullous Dermatosis, J Invest Dermatol, vol.138, issue.7, pp.1473-1480, 2018.

G. Fortuna, J. C. Salas-alanis, E. Guidetti, and M. P. Marinkovich, A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity?, J Am Acad Dermatol, vol.66, issue.6, pp.988-94, 2012.

D. G. Paige, J. N. Leonard, F. Wojnarowska, and L. Fry, Linear IgA disease and ulcerative colitis, Br J Dermatol, vol.136, issue.5, pp.779-82, 1997.

C. Talhari, N. Mahnke, T. Ruzicka, and M. Megahed, Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent, Clin Exp Dermatol, vol.30, issue.3, pp.297-305, 2005.

H. S. Young and I. H. Coulson, Linear IgA disease: successful treatment with cyclosporin, Br J Dermatol, vol.143, issue.1, pp.204-209, 2000.

N. Kenani, A. Mebazaa, and M. Denguezli, Childhood linear IgA bullous dermatosis in Tunisia, Pediatr Dermatol, vol.26, issue.1, pp.28-33, 2009.

K. Monia, A. K. Amel, and K. , Linear IgA bullous dermatosis in tunisian children: 31 cases, Indian J Dermatol, vol.56, issue.2, pp.153-162, 2011.

P. Joly, S. Baricault, A. Sparsa, and P. Bernard, Incidence and mortality of bullous pemphigoid in France, J Invest Dermatol, vol.132, issue.8, pp.1998-2004, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00729013

B. Cortés, G. Marazza, and L. Naldi, Mortality of bullous pemphigoid in Switzerland: a prospective study, Br J Dermatol, vol.165, issue.2, pp.368-74, 2011.

P. Joly, J. C. Roujeau, J. Benichou, C. Picard, B. Dreno et al., A comparison of oral and topical corticosteroids in patients with bullous pemphigoid, N Engl J Med, vol.346, issue.5, pp.321-328, 2002.

D. N. Kolbach, J. J. Remme, W. H. Bos, and M. F. Jonkman, Bullous pemphigoid successfully controlled by tetracycline and nicotinamide, Br J Dermatol, vol.133, issue.1, pp.88-90, 1995.

F. Bouscarat, O. Chosidow, C. Picard-dahan, and V. Sakiz, Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases, J Am Acad Dermatol, vol.34, issue.4, pp.683-687, 1996.

P. G. Stavropoulos, E. Soura, and A. , Drug-induced pemphigoid: a review of the literature, J Eur Acad Dermatol Venereol, vol.28, issue.9, pp.1133-1173, 2014.

H. Tanaka and T. Ishii, Analysis of patients with drug-induced pemphigoid using the Japanese Adverse Drug Event Report database, J Dermatol, vol.46, issue.3, pp.240-244, 2019.

M. Benzaquen, L. Borradori, and P. Berbis, Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland, J Am Acad Dermatol, vol.78, issue.6, pp.1090-1096, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01757606

I. García-díez, M. Ivars-lleó, D. López-aventín, and N. Ishii, Bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors. Eight cases with clinical and immunological characterization, Int J Dermatol, vol.57, issue.7, pp.810-816, 2018.

J. Béné, G. Moulis, I. Bennani, M. Auffret, and P. Coupe, Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database, Br J Dermatol, vol.175, issue.2, pp.296-301, 2016.

C. Zumelzu, M. Alexandre, L. Roux, C. Weber, and P. , Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature, Front Med, vol.5, pp.268-290, 2018.

N. Kremer, I. Snast, E. S. Cohen, and E. Hodak, Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature, Am J Clin Dermatol, vol.20, issue.2, pp.209-216, 2019.

, PNDS, vol.52

L. Roux-villet, C. Prost-squarcioni, and C. , Epidermolysis bullosa acquisita:literature review, Ann Dermatol Venereol, vol.138, issue.3, pp.228-274, 2011.

R. J. Ludwig, Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita, ISRN Dermatol, vol.2013, p.812029, 2013.

C. Zumelzu, L. Roux-villet, C. Loiseau, P. Busson, and M. , Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita, J Invest Dermatol, vol.131, issue.12, pp.2386-93, 2011.

S. N. Wong and S. H. Chua, Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Br J Dermatol, vol.147, issue.3, pp.476-80, 2002.

L. Delgado, V. Aoki, C. Santi, T. Gabbi, M. Sotto et al., Clinical and immunopathological evaluation of epidermolysis bullosa acquisita, Clin Exp Dermatol, vol.36, issue.1, pp.12-20, 2011.

P. Iranzo, J. E. Herrero-gonzález, J. M. Mascaró-galy, R. Suárez-fernández, and A. España, Epidermolysis bullosa acquisita : a retrospective analysis of 12 patients evaluated in four tertiary hospitals in Spain, Br J Dermatol, vol.171, issue.5, pp.1022-1052, 2014.

J. H. Kim, Y. H. Kim, and S. C. Kim, Epidermolysis bullosa acquisita : a retrospective clinical analysis of 30 cases, Acta Derm Venereol, vol.91, issue.3, pp.307-319, 2011.

M. Mayuzumi, M. Akiyama, W. Nishie, S. Ukae, M. Abe et al., Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature, Br J Dermatol, vol.155, issue.5, pp.1048-52, 2006.

W. R. Gammon, R. A. Briggaman, D. T. Woodley, P. W. Heald, and C. E. Wheeler, Epidermolysis bullosa acquisita-a pemphigoid-like disease, J Am Acad Dermatol, vol.11, issue.5, pp.820-852, 1984.

K. Wozniak, T. Kazama, and C. Kowalewski, A practical technique for differentiation of subepidermal bullous diseases : localization of in vivo-bound IgG by laser scanning confocal microscopy, Arch Dermatol, vol.139, issue.8, pp.1007-1018, 2003.

M. Chen, G. H. Kim, L. Prakash, and D. T. Woodley, Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen, Autoimmunity, vol.45, issue.1, p.23, 2012.

M. Chen, E. A. O'toole, J. Sanghavi, N. Mahmud, D. Kelleher et al., The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn's disease have autoantibodies to type VII collagen, J Invest Dermatol, vol.118, issue.6, pp.1059-64, 2002.

H. H. Roenigk, J. G. Ryan, W. F. Bergfeld, and . Epidermolysis, Report of three cases and review of all published cases, Arch Dermatol, vol.103, issue.1, pp.1-10, 1971.

S. Edwards, S. H. Wakelin, F. Wojnarowska, R. A. Marsden, G. Kirtschig et al., Bullous pemphigoid and epidermolysis bullosa acquisita: presentation, prognosis, and immunopathology in 11 children, Pediatr Dermatol, vol.15, issue.3, pp.184-90, 1998.

A. P. Hughes and J. P. Callen, Epidermolysis bullosa acquisita responsive to dapsone therapy, J Cutan Med Surg, vol.5, issue.5, pp.397-406, 2001.

P. Berbis and Y. Privat,

, Ann Dermatol Venereol, vol.116, issue.4, pp.301-308, 1989.

.. Pnds, , 2016.

I. Chimanovitch, E. Schmidt, and G. Messer, IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of the BP180 in pemphigoid gestationis, J Invest Dermatol, vol.113, issue.1, pp.140-142, 1999.

D. Roger, L. Vaillant, and A. Fignon, Specific pruritic diseases of pregnancy : a prospective study of 3192 pregnant women, Arch Dermatol, vol.130, issue.6, pp.734-743, 1994.

L. Huilaja, K. Mäkikallio, and R. Sormunen, Gestational Pemphigoid : Placental Morphology and Function, Acta Derm Venereol, vol.93, issue.1, pp.33-41, 2013.

M. Mokni, M. Fourati, and I. Karoui, Pemphigoïde gravidique. Étude de 20 cas, Ann Dermatol Venereol, vol.131, pp.953-956, 2004.

C. C. Chi, S. H. Wang, and R. Charles-holmes, Pemphigoid gestationis : early onset and blister formation are associated with adverse pregnancy outcomes, Br J Dermatol, vol.160, issue.6, pp.1222-1230, 2009.

R. E. Jenkins, S. Hern, and M. M. Black, Clinical features and management of 87 patients with pemphigoid gestationis, Clin Exp Dermatol, vol.24, issue.4, pp.255-264, 1999.

L. Valeyrie, B. Lebrun-vignes, and N. Bodak, Pemphigoïde de la grossesse : traitement par corticothérapie locale de classe I, Ann Dermatol Venereol, vol.128, issue.5, pp.638-678, 2001.

J. K. Shornick and M. M. Black, Fetal risk in herpes gestationis, J Am Acad Dermatol, vol.26, issue.1, pp.63-71, 1992.

L. Amato, S. Mei, and I. Gallerani, A case of herpes gestationis : persistent disease or conversion to bullous pemphigoid, J Am Acad Dermatol, vol.49, issue.2, pp.302-309, 2003.

C. C. Chi, R. T. Mayon-white, and F. T. Woknarowska, Safety of Topical Corticosteroids in Pregnancy : A Population-Based Cohort Study, J Invest Dermatol, vol.131, issue.4, pp.884-91, 2011.

G. Cianchini, C. Masini, F. Lupi, R. Corona, D. Pità et al., Severe persistent pemphigoid gestationis : long-term remission with rituximab, Br J Dermatol, vol.157, issue.2, pp.388-397, 2007.

S. Boulinguez, C. Bedane, and C. Prost, Chronic pemphigoid gestationis : comparative clinical and immunopathological study of 10 patients, Dermatology, vol.206, issue.2, pp.113-122, 2003.

A. Czernik, M. Camilleri, M. R. Pittelkow, and S. A. Grando, Paraneoplastic autoimmune multiorgan syndrome: 20 years after, Int J Dermatol, vol.50, issue.8, pp.905-919, 2011.

D. Mimouni, G. J. Anhalt, and Z. Lazarova, Paraneoplastic pemphigus in children and adolescents, Br J Dermatol, vol.147, issue.4, pp.725-757, 2002.

Y. Huang, J. Li, and X. Zhu, Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus, Arch Dermatol Res, vol.301, issue.10, pp.703-712, 2009.

S. E. Billet, S. A. Grando, and M. R. Pittelkow, Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis, Autoimmunity, vol.39, issue.7, pp.617-647, 2006.

F. Maldonado, M. R. Pittelkow, and J. H. Ryu, Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome, Respirology, vol.14, issue.1, pp.129-162, 2009.

H. C. Nousari, R. Deterding, and H. Wojtczack, The mechanism of respiratory failure in paraneoplastic pemphigus, N Engl J Med, vol.340, issue.18, pp.1406-1416, 1999.

A. Tsuchisaka, S. Numata, and K. Teye, Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients, J Invest Dermatol, vol.136, issue.2, pp.399-408, 2016.

S. Leger, D. Picard, and S. Ingen-housz-oro, Prognostic factors of paraneoplastic pemphigus, Arch Dermatol, vol.148, issue.10, pp.1165-72, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00727669

P. Joly, C. Richard, and D. Gilbert, Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus, J Am Acad Dermatol, vol.43, issue.4, pp.619-645, 2000.

G. J. Anhalt, Paraneoplastic pemphigus, J Investig Dermatol Symp Proc, vol.9, issue.1, pp.29-33, 2004.

Y. Fang, L. Zhao, and F. Yan, A critical role of surgery in the treatment for paraneoplastic pemphigus caused by localized Castleman's disease, Med Oncol, vol.27, issue.3, pp.907-918, 2010.

J. W. Frew and D. F. Murrell, Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome), Dermatol Clin, vol.29, issue.4, pp.607-619

J. V. Williams, J. G. Marks, and E. M. Billingsley, Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus, Br J Dermatol, vol.142, issue.3, pp.506-514, 2000.

L. R. Becker, B. C. Bastian, and U. Wesselmann, Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy, Eur J Dermatol, vol.8, issue.8, pp.551-554, 1998.

T. Anan, F. Shimizu, and Y. Hatano, Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: a case report and review of cases treated with rituximab, J Dermatol, vol.38, issue.11, pp.1084-1093, 2011.

T. Hirano, Y. Higuchi, and H. Yuki, Rituximab Monotherapy and Rituximab-Containing Chemotherapy Were Effective for Paraneoplastic Pemphigus Accompanying Follicular Lymphoma, but not for Subsequent Bronchiolitis Obliterans, J Clin Exp Hematop, vol.55, issue.2, pp.83-91, 2015.

P. Joly and N. Litrowski, Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis), Clin Dermatol, vol.29, issue.4, pp.432-438, 2011.

S. Brenner and Y. Wohl, A survey of sex differences in 249 pemphigus patients and possible explanations. Skinmed, vol.6, pp.163-168, 2007.

M. Amagai, K. Tsunoda, and D. Zillikens, The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile, J Am Acad Dermatol, vol.40, issue.2, pp.167-70, 1999.

S. Brenner, A. Bialy-golan, and V. Ruocco, Drug-induced pemphigus, Clin Dermatol, vol.16, issue.3, pp.393-400, 1998.

A. Maruani, M. C. Machet, and A. Carlotti, Immunostaining with antibodies to desmoglein provides the diagnosis of drug-induced pemphigus and allows prediction of outcome, Am J Clin Pathol, vol.130, issue.3, pp.369-74, 2008.

M. B. Mustafa, S. R. Porter, B. R. Smoller, and C. Sitaru, Oral mucosal manifestations of autoimmune skin diseases, Autoimmun Rev, vol.14, issue.10, pp.930-51, 2015.

V. Ruocco, E. Ruocco, L. Schiavo, and A. , Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies, Clin Dermatol, vol.31, issue.4, pp.374-381, 2013.

N. Meyer and L. Misery, Geoepidemiologic considerations of auto-immune pemphigus, Autoimmun Rev, vol.9, issue.5, pp.379-82, 2010.

L. A. Diaz, S. A. Sampaio, and E. A. Rivitti, Endemic pemphigus foliaceus (Fogo Selvagem): II. Current and historic epidemiologic studies, J Invest Dermatol, vol.92, issue.1, pp.4-12, 1989.

K. A. James, D. A. Culton, and L. A. Diaz, Diagnosis and clinical features of pemphigus foliaceus, Dermatol Clin, vol.29, issue.3, pp.405-417, 2011.

R. M. Knudson, A. N. Kalaaji, and A. J. Bruce, The management of mucous membrane pemphigoid and pemphigus, Dermatol Ther, vol.23, issue.3, pp.268-80, 2010.

C. S. Foster and . Pemphigoid, Trans Am Ophthalmol Soc, vol.84, pp.527-663, 1986.

F. Bertram, E. B. Bröcker, D. Zillikens, and E. Schmidt, Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, J Dtsch Dermatol Ges, vol.7, issue.5, pp.434-474, 2009.

K. A. Rashid, H. M. Gürcan, and A. R. Ahmed, Antigen specificity in subsets of mucous membrane pemphigoid, J Invest Dermatol, vol.126, issue.12, pp.2631-2637, 2006.

L. S. Chan, A. A. Majmudar, and H. H. Tran, Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid, J Invest Dermatol, vol.108, issue.6, pp.848-53, 1997.

E. P. Smith, T. B. Taylor, L. J. Meyer, and J. J. Zone, Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid, J Invest Dermatol, vol.101, issue.4, pp.619-642, 1993.

R. F. Ghohestani, J. F. Nicolas, P. Rousselle, and A. L. Claudy, Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid, J Invest Dermatol, vol.107, issue.1, pp.136-145, 1996.
URL : https://hal.archives-ouvertes.fr/hal-00314049

C. A. Egan, Z. Lazarova, and T. N. Darling, Anti-epiligrin cicatricial pemphigoid and relative risk for cancer, Lancet, vol.357, issue.9271, pp.1850-1851, 2001.

A. R. Ahmed and S. M. Hombal, Cicatricial pemphigoid, Int J Dermatol, vol.25, issue.2, pp.90-96, 1986.

J. M. Martín, I. Pinazo, and I. Molina, Cicatricial pemphigoid of the Brunsting-Perry type, Int J Dermatol, vol.48, issue.3, pp.293-297, 2009.

L. S. Chan, A. R. Ahmed, G. J. Anhalt, W. Bernauer, K. D. Cooper et al., The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators, Arch Dermatol, vol.138, issue.3, pp.370-379, 2002.

M. Gillies, Local interferon alfa-2b for ocular cicatricial pemphigoid, Br J Ophthalmol, vol.80, issue.10, p.927, 1996.

, PNDS, 2016.

C. Gaudy-marqueste, Autres immunosuppresseurs : azathioprine (Imurel®), mycophénolate mofétil (Cellcept®), cyclophosphamide (Endoxan®), Ann Dermatol Venereol, vol.134, pp.949-56, 2007.

X. Roblin, A. Oussalah, J. M. Phelip, and L. Peyrin-biroulet, Métabolisme de l'azathioprine : que faut-il faire ou ne pas faire en pratique clinique ? Gastroentérologie Clinique et Biologique, vol.33, pp.172-177, 2009.

, Foster CS Pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients, Cornea, vol.10, p.185, 1991.

E. M. Munyangango, L. Roux-villet, C. Doan, S. Pascal, F. Soued et al., Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid, Br J Dermatol, vol.168, issue.2, pp.381-90, 2013.

K. Scott, A. Morris, and B. Marais, Medical student use of digital learning resources, Clin Teach, vol.15, issue.1, pp.29-33, 2018.

L. Wynter, A. Burgess, E. Kalman, J. E. Heron, and J. Bleasel, Medical students: what educational resources are they using, BMC Med Educ, vol.19, issue.1, p.36, 2019.

S. Alipour, A. Moini, S. Jafari-adli, N. Gharaie, and K. Mansouri, Comparison of Teaching about Breast Cancer via Mobile or Traditional Learning Methods in Gynecology Residents, Asian Pac J Cancer Prev, vol.13, issue.9, pp.4593-4598, 2012.

M. Abdolrasulnia, B. C. Collins, L. Casebeer, T. Wall, C. Spettell et al., Using email reminders to engage physicians in an Internet-based CME intervention, BMC Med Educ, vol.4, issue.1, p.17, 2004.

S. Kim, L. R. Willett, D. J. Murphy, K. O'rourke, R. Sharma et al., Impact of an Evidence-Based Medicine Curriculum on Resident Use of Electronic Resources: A Randomized Controlled Study, J Gen Intern Med, vol.23, issue.11, pp.1804-1812, 2008.

P. Bg, P. Ab, M. D. Tm, M. D. Tb, M. D. Sjm et al., The effectiveness of an internet based tutorial in improving primary care physicians' skin cancer triage skills, J Cancer Educ, vol.17, issue.1, pp.7-11, 2002.

C. M. Weston, C. N. Sciamanna, and D. B. Nash, Evaluating Online Continuing Medical Education Seminars: Evidence for Improving Clinical Practices, Am J Med Qual, vol.23, issue.6, pp.475-83, 2008.

S. M. Salter, A. Karia, F. M. Sanfilippo, and R. M. Clifford, Effectiveness of E-learning in Pharmacy Education, Am J Pharm Educ. 1 mai, vol.78, issue.4, p.83, 2014.

D. S. Bell, C. E. Harless, J. K. Higa, E. L. Bjork, R. A. Bjork et al., Knowledge Retention after an Online Tutorial: A Randomized Educational Experiment among Resident Physicians, J Gen Intern Med, vol.23, issue.8, pp.1164-71, 2008.

. Cours-sur-le-pemphigus-profond, , p.30

, Cours sur les dermatoses bulleuses auto-immunes sous épidermiques

. Cours, , p.47

, Cours sur les épidermolyses bulleuses acquises, p.58

. Cours,

, Cours sur la pemphigoïde des muqueuses, pp.77-78